Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population

Metabolic Syndrome Clinical Trial

Official title:

Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01176630
• Other study ID #: 10311
• Status: Completed
• Phase: N/A
• First received: August 4, 2010
• Last updated: February 24, 2012
• Start date: August 2010
• Est. completion date: December 2010

Study information

• Verified date: February 2012
• Source: Winthrop University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The study is a survey to answer the specific question, "What is the prevalence of metabolic syndrome in maintenance hemodialysis patients?" Metabolic syndrome is a cluster of conditions that increase an individual's risk for developing cardiovascular disease and diabetes.

Description:

Risk factors for metabolic syndrome will be collected for each consented patient. They include elevated serum triglycerides, reduced HDL cholesterol, hypertension, elevated fasting blood sugar concentration and abdominal obesity. The investigator will measure waist circumference of each consented patient in a secure area according to standardized procedures. The other data is available from the patient's medical record.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 108
• Est. completion date: December 2010
• Est. primary completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients undergoing maintenance hemodialysis equal to or greater than 3 months

• Patient at lest 18 years of age

• Availability of all data in the medical record for classification of the metabolic syndrome, including serum triglycerides, serum HDL-cholesterol, systolic BP and diastolic BP, and serum glucose

Exclusion Criteria:

• Patients unwilling or unable to give informed consent to participate

• Patients with a history of thyroid disease

• Patients unable to stand upright

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Metabolic Syndrome
• Metabolic Syndrome X
• Syndrome

Locations

Country	Name	City	State
United States	Winthrop University Hospital Outpatient Dialysis Unit	Mineola	New York

Sponsors (1)

Lead Sponsor	Collaborator
Winthrop University Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percent of maintenance patients with at least three risk factors of metabolic syndrome		6 months	No